FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

ABT

Abbott LaboratoriesNYSE · Health Care Equipment · Health Care
Previous close
102.36
Change
+0.33 / +0.32%
FinDog View
Neutral
52-Week Range
81.97 – 137.49
P/E (TTM)
33.2
Forward P/E
18.1
Based on consensus earnings for the next 12 months
Market Cap
$177B
1M
−7.26%
S&P 500 −2.41% over same period
Volume / Avg Volume
5.2M / 7.5M
0.69× average

Price History

Closing price · USD1M6M1Y5Y
80100120140160FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 EarningsFY25 Q2 EarningsFY25 Q1 Earnings2021-092022-122024-032025-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 31.81M6M1Y5Y
10203040502023-052024-032025-012025-112026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-16$12.6B1.31 / 1.29+1.87%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-16$11.2B1.15 / 1.16+1.40%Pending
FY2025 Q4
Quarter ended 2025-12
2026-01-22—— / —−1.10%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-15—— / —−1.41%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-17—— / —+2.62%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-16—— / —+0.99%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 66 of its 5-year rangeMid-range
5-year range 15.7 – 37.7 · Median 31.8
Last 4 quarters: $793M in buybacks + $4.2B in dividends, 2.81% of market cap combined
P/E (TTM)
33.2
P/B
3.5
P/S
3.9
Dividend Yield
1.98%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.6% on average on the first trading day after, rising 4 times
Most recent +1.87%
Volatility & Correlation
1-year beta 0.03 · Correlation with S&P 500 0.01Low beta
Annualized volatility 27% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 1 · $0.17MSell 3 · $46.9MNet selling $46.7M
  • 09-02MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERSell$0.00M27 shares · Avg price 109.54
  • 08-25Ford Robert BCHAIRMAN AND CEOSell$46.2M398,832 shares · 2 trades · Avg price 115.85
  • 08-11Morrone Louis H.EXECUTIVE VICE PRESIDENTSell$0.64M5,850 shares · Avg price 109.83
  • 05-07Stratton John GDirectorBuy$0.17M2,000 shares · Avg price 86.82
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q111.16+7.8%56.2%1.351.080.920.61
FY2025 Q411.46+4.4%57.0%2.251.782.631.01
FY2025 Q311.37+6.9%55.4%2.061.642.290.94
FY2025 Q211.14+7.4%56.4%2.051.781.551.01
FY2025 Q110.36+4.0%56.9%1.691.330.930.76
FY2024 Q410.97+7.2%55.0%1.919.232.155.26
FY2024 Q310.64+4.9%55.8%1.861.652.150.94
FY2024 Q210.38+4.0%55.6%1.671.301.430.74
FY2024 Q19.96+2.2%55.2%1.391.230.630.70
FY2023 Q410.24+1.5%55.5%1.781.592.280.91
FY2023 Q310.14−2.6%54.6%1.651.441.320.82
FY2023 Q29.98−11.4%55.1%1.541.380.700.78

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
ABTAbbott Laboratories$177B33.2+7.8%56.2%−7.26%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare